Position in UTHR
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$23,298
-$301,655 QoQ
Shares Held
43
-92.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#768
of 870 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Clearstead Advisors, LLC holds $1,662,942 across 40 Drug Manufacturers - Specialty & Generic names. UTHR ranks #9 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
14,233 | $1,022,783 | |
| 2 | HLN |
Haleon plc
|
20,447 | $190,770 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,765 | $93,678 | |
| 4 | VTRS |
Viatris Inc
|
4,374 | $69,459 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
345 | $58,146 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
2,008 | $49,416 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
3,338 | $48,367 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
1,343 | $46,561 |
All Filings in UTHR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,298 | 43 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $324,953 | 548 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $551,079 | 1,131 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $117,378 | 280 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $73,848 | 257 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $30,518 | 99 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||